Jóźwiak Z - Search Results

1

Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells.

Łubgan D, Jóźwiak Z, Grabenbauer GG, Distel LV. Łubgan D, et al. Among authors: jozwiak z. Cell Mol Biol Lett. 2009;14(1):113-27. doi: 10.2478/s11658-008-0037-2. Epub 2008 Oct 10. Cell Mol Biol Lett. 2009. PMID: 18850074 Free PMC article.

2

Toxicity of doxorubicin-transferrin conjugate is connected to the modulation of Wnt/β-catenin pathway in human leukemia cells.

Szwed M, Kania KD, Jozwiak Z. Szwed M, et al. Among authors: jozwiak z. Leuk Res. 2015 Oct;39(10):1096-102. doi: 10.1016/j.leukres.2015.07.003. Epub 2015 Jul 13. Leuk Res. 2015. PMID: 26271413

3

Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells.

Szwed M, Jozwiak Z. Szwed M, et al. Among authors: jozwiak z. Mutat Res Genet Toxicol Environ Mutagen. 2014 Sep 1;771:53-63. doi: 10.1016/j.mrgentox.2014.06.007. Epub 2014 Jun 30. Mutat Res Genet Toxicol Environ Mutagen. 2014. PMID: 25308442

4

Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin-transferrin conjugate in human leukemia cell lines.

Szwed M, Kania KD, Jozwiak Z. Szwed M, et al. Among authors: jozwiak z. Leuk Lymphoma. 2015 May;56(5):1475-83. doi: 10.3109/10428194.2014.955022. Epub 2014 Oct 27. Leuk Lymphoma. 2015. PMID: 25166006

5

The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.

Rogalska A, Gajek A, Szwed M, Jóźwiak Z, Marczak A. Rogalska A, et al. Among authors: jozwiak z. Toxicol In Vitro. 2011 Dec;25(8):1712-20. doi: 10.1016/j.tiv.2011.08.009. Epub 2011 Aug 27. Toxicol In Vitro. 2011. PMID: 21896327

6

[Transferrin conjugates in the anticancer therapy].

Lubgan D, Marczak A, Distel L, Jóźwiak Z. Lubgan D, et al. Among authors: jozwiak z. Postepy Biochem. 2006;52(1):72-9. Postepy Biochem. 2006. PMID: 16869304 Review. Polish.

7

[Pharmacological mechanisms of Doxorubicin activity (DOX) - current state of knowledge].

Łubgan D, Marczak A, Walczak M, Distel L, Jóźwiak Z. Łubgan D, et al. Among authors: jozwiak z. Przegl Lek. 2006;63(9):782-8. Przegl Lek. 2006. PMID: 17479870 Review. Polish.

8

Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.

Szwed M, Laroche-Clary A, Robert J, Jozwiak Z. Szwed M, et al. Among authors: jozwiak z. Cell Oncol (Dordr). 2016 Apr;39(2):107-18. doi: 10.1007/s13402-015-0256-2. Epub 2015 Nov 26. Cell Oncol (Dordr). 2016. PMID: 26611752 Free PMC article.

9

Assessment of pro-apoptotic activity of doxorubicin-transferrin conjugate in cells derived from human solid tumors.

Szwed M, Kania KD, Jozwiak Z. Szwed M, et al. Among authors: jozwiak z. Int J Biochem Cell Biol. 2016 Jan;70:57-67. doi: 10.1016/j.biocel.2015.10.020. Epub 2015 Oct 28. Int J Biochem Cell Biol. 2016. PMID: 26520467

10

Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin.

Szwed M, Kania KD, Jozwiak Z. Szwed M, et al. Among authors: jozwiak z. Cell Oncol (Dordr). 2014 Dec;37(6):421-8. doi: 10.1007/s13402-014-0205-5. Epub 2014 Nov 20. Cell Oncol (Dordr). 2014. PMID: 25410120 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results